Interventional oncology group
Ablation, liver, radioembolization
Research aim
Interventional oncology is a fast-moving subspeciality providing image-guided treatment of cancer by interventional radiologists. Our aim is to help develop, evaluate and implement innovations in this field.
About us
Our research group is dedicated to advancing cancer care through clinically oriented studies that leverage minimally invasive, image-guided techniques. By integrating patient care with research, we rapidly translate innovative ideas into clinical studies and ultimately into practice. This process is facilitated by close collaborations with referring clinicians, hospitals, and private partners.
Our primary focus is on developing cost-effective, less invasive treatments that require fewer resources, both in terms of personnel and environmental impact. Our main research areas include radioembolization and thermal ablation for liver tumors.
In the field of radioembolization, our research aims to establish safe and effective dosages for yttrium-90 and holmium-166 microspheres across various tumor types. We are also exploring innovations to enhance clinical workflow efficiency and anti-tumor efficacy, such as advanced catheter designs, administration systems, and intra-arterial drug injections.
Our thermal ablation research is centered on the Hepatic Arteriography and C-arm CT Guided Ablation (HepACAGA) technique, robotic needle guidance, and other ablative methods. These techniques are applied to patients with primary liver cancer, liver metastases, renal cancer, and other tumor types.